Comparison of Intermittent versus Continuous Superior Venal Caval Oxygen Saturation Monitoring in Early Goal Directed Therapy in Septic Shock : A Systematic Review
Thieme. All rights reserved..
Early goal directed therapy (EGDT) is a bundle of care (monitoring ScvO 2 and lactate along with clinical parameters and instituting therapy) that has shown to improve outcomes in patients with septic shock. We conducted a systematic review of clinical trials and observational studies to compare intermittent versus continuous monitoring of ScvO 2 . We did major database searches till August 2020. Hospitalized children (>2 months age) and adults with septic shock were included. The intervention was "intermittent ScvO 2 monitoring," and the comparator was "continuous ScvO 2 monitoring." The primary outcome is "all-cause mortality." Of 564 citations, 3 studies ( n = 541) including both children and adults were included in the analysis. There was no significant difference in the "overall/all-cause mortality" (two randomized controlled trials; 258 participants) between the "intermittent" and "continuous" ScvO 2 monitoring groups (relative risk [RR]: 1.00; 95% confidence interval [CI]: 0.8-1.24). However, a single observational study (283 participants) showed a significant increase in mortality in the intermittent group (RR: 1.46; 95% CI: 1.03-2.05). The GRADE evidence generated for "overall/all-cause mortality" was of "moderate certainty." To conclude, the present meta-analysis did not find any significant difference between "intermittent" and "continuous" ScvO 2 monitoring in patients with septic shock.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:11 |
---|---|
Enthalten in: |
Journal of pediatric intensive care - 11(2022), 4 vom: 03. Dez., Seite 267-274 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Sankar, Jhuma Mondal [VerfasserIn] |
---|
Links: |
---|
Themen: |
Goal directed therapy |
---|
Anmerkungen: |
Date Revised 19.11.2022 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.1055/s-0041-1729742 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM349014337 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM349014337 | ||
003 | DE-627 | ||
005 | 20231226041634.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1055/s-0041-1729742 |2 doi | |
028 | 5 | 2 | |a pubmed24n1163.xml |
035 | |a (DE-627)NLM349014337 | ||
035 | |a (NLM)36388075 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Sankar, Jhuma Mondal |e verfasserin |4 aut | |
245 | 1 | 0 | |a Comparison of Intermittent versus Continuous Superior Venal Caval Oxygen Saturation Monitoring in Early Goal Directed Therapy in Septic Shock |b A Systematic Review |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 19.11.2022 | ||
500 | |a published: Electronic-eCollection | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a Thieme. All rights reserved. | ||
520 | |a Early goal directed therapy (EGDT) is a bundle of care (monitoring ScvO 2 and lactate along with clinical parameters and instituting therapy) that has shown to improve outcomes in patients with septic shock. We conducted a systematic review of clinical trials and observational studies to compare intermittent versus continuous monitoring of ScvO 2 . We did major database searches till August 2020. Hospitalized children (>2 months age) and adults with septic shock were included. The intervention was "intermittent ScvO 2 monitoring," and the comparator was "continuous ScvO 2 monitoring." The primary outcome is "all-cause mortality." Of 564 citations, 3 studies ( n = 541) including both children and adults were included in the analysis. There was no significant difference in the "overall/all-cause mortality" (two randomized controlled trials; 258 participants) between the "intermittent" and "continuous" ScvO 2 monitoring groups (relative risk [RR]: 1.00; 95% confidence interval [CI]: 0.8-1.24). However, a single observational study (283 participants) showed a significant increase in mortality in the intermittent group (RR: 1.46; 95% CI: 1.03-2.05). The GRADE evidence generated for "overall/all-cause mortality" was of "moderate certainty." To conclude, the present meta-analysis did not find any significant difference between "intermittent" and "continuous" ScvO 2 monitoring in patients with septic shock | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a ScvO 2 monitoring | |
650 | 4 | |a goal directed therapy | |
650 | 4 | |a mortality | |
650 | 4 | |a sepsis | |
650 | 4 | |a septic shock | |
700 | 1 | |a Das, Rashmi Ranjan |e verfasserin |4 aut | |
700 | 1 | |a Kumar, Udhaya Vijaya |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Journal of pediatric intensive care |d 2012 |g 11(2022), 4 vom: 03. Dez., Seite 267-274 |w (DE-627)NLM234768762 |x 2146-4618 |7 nnns |
773 | 1 | 8 | |g volume:11 |g year:2022 |g number:4 |g day:03 |g month:12 |g pages:267-274 |
856 | 4 | 0 | |u http://dx.doi.org/10.1055/s-0041-1729742 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 11 |j 2022 |e 4 |b 03 |c 12 |h 267-274 |